Lung cancer screening

 

 

 

 

 

 

 

Successful lung

cancer screening
starts here

Lung cancer is a leading cause of cancer death

 

Low-dose CT screening for lung cancer has shown to detect lung cancer at earlier stages, when its most curable, as well as reduce mortality by 20 percent compared to standard chest x-ray.*

 

But developing a lung cancer screening program presents new challenges for radiology, and a comprehensive solution is critical to a program’s success.

 

Philips offers the full range tools and resources you need to make your program a success.

 

Learn how our CT solutions can help your organization.

Contact us
*
*
*
*
*
*
*
*
*
*
*
*
*

* Required fields

Strong support at every step

 

From education and scanning to advanced visualization and patient management, Philips offers the full range of tools you need to help you create an effective, reimbursement-compliant lung cancer screening program.

Program setup and education

 

Our specialist teams provide consultative services to help you get up and running including training module tools for staff, outreach to attract referrals, an online education portal, ACR and CMS guidelines and assistance with the reimbursement landscape.

Program setup and education

 

Our specialist teams provide consultative services to help you get up and running including training module tools for staff, outreach to attract referrals, an online education portal, ACR and CMS guidelines and assistance with the reimbursement landscape.

CT scanning solutions

 

Philips offers a full portfolio of 27 systems compliant with CMS and ACR guidelines for the excellent image quality at low dose that lung cancer screening demands.

Monitor disease progression

 

In addition to providing you tools for screening, Philips Tumor Tracking technology helps you monitor changes in disease status and progression, as well as assess therapy response.

Patient management

 

Our patient management tools are built for screening, so you can operate compliantly and efficiently. We offer customization to meet your needs, and our DynaLync software provides automation of routine or instructive tasks for patient follow-up and tracking.

Lung Cancer Screening Solutions

CT Scanners

 

Portfolio of CT solutions

Image Quality & Dose Management

 

Leading imaging and dose management software

DynaLync

 

Automate routine tasks based on clinical protocols

Lung Nodule Assessment

 

Enterprise-wide advanced visualization and analysis

PET/CT Scanners

 

Portfolio of PET/CT solutions

*The National Lung Screening Trial research team. Reduced lung cancer mortality with low dose computed tomographic screening. N Engl J Med, 2011; 365:395-409.

**CMS (Center for Medicare and Medicaid services) have guidelines to use the volumetric CT dose index (CTDIvol) of ≤ 3.0 mGy (milligray) for standard size patients (defined to be 5’7”and approximately 155 pounds) with appropriate reductions in CTDIvol for smaller patients and appropriate increases in CTDIvol for larger patients.

World Cancer Research Fund International Fact Sheet, 2015.